Symptomatic neurosyphilis, unspecified
ICD-10 A52.10 is a billable code used to indicate a diagnosis of symptomatic neurosyphilis, unspecified.
Symptomatic neurosyphilis is a manifestation of syphilis that affects the central nervous system, occurring in individuals who have not received adequate treatment for the infection. It can present with a variety of neurological symptoms, including headaches, altered mental status, seizures, and other cognitive impairments. The condition can arise at any stage of syphilis but is most commonly seen in the late stages. Diagnosis typically involves a combination of clinical evaluation, serological testing for syphilis, and cerebrospinal fluid analysis to identify Treponema pallidum, the causative agent. Treatment usually involves high-dose intravenous penicillin G, which is effective in eradicating the infection and alleviating symptoms. However, early diagnosis and treatment are crucial to prevent irreversible neurological damage. Given the complexity of the disease and its implications for public health, including the need for contact tracing and management of sexual partners, it is essential for healthcare providers to be vigilant in recognizing and addressing symptomatic neurosyphilis.
Detailed history of syphilis infection, treatment history, and neurological assessment findings.
Patients presenting with neurological symptoms and a history of syphilis.
Ensure all relevant tests and treatments are documented to support the diagnosis.
Comprehensive neurological examination findings and any imaging or CSF analysis results.
Patients with cognitive decline or seizures with a known history of syphilis.
Document the relationship between neurological symptoms and syphilis to justify the diagnosis.
Used for administering penicillin G in severe cases of neurosyphilis.
Document the dosage, duration, and patient response to treatment.
Infectious disease specialists should ensure proper administration protocols are followed.
Common symptoms include headaches, cognitive impairment, seizures, and changes in personality or behavior. Patients may also experience visual disturbances or other neurological deficits.
Diagnosis involves a combination of clinical evaluation, serological testing for syphilis, and cerebrospinal fluid analysis to detect Treponema pallidum and assess for inflammation.
